Earnings Feed
Start Free
Home/Filings/4/0001140361-10-011221
4//SEC Filing

McGuinness Michael 4

Accession 0001140361-10-011221

CIK 0001001316other
View on SEC.govCompany Profile

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 6:15 PM ET

Size

13.6 KB

Accession

0001140361-10-011221

Insider Transaction Report

Form 4
Period: 2010-03-03
MANHATTAN PHARMACEUTICALS INCMHAN
McGuinness Michael
COO & CFO
Transactions
  • Award

    Stock Options

    2010-03-03+2,000,000→ 2,000,000 total
    Exercise: $0.07Exp: 2020-03-02→ Common Stock (2,000,000 underlying)
Holdings

  • Common Stock

    10,000

  • Stock Options

    Exercise: $0.70Exp: 2016-07-10→ Common Stock (220,000 underlying)
    220,000

  • Warrant

    Exercise: $0.20Exp: 2013-09-10→ Common Stock (24,000 underlying)
    24,000

  • Stock Options

    Exercise: $1.35Exp: 2016-07-10→ Common Stock (60,000 underlying)
    60,000

  • Stock Options

    Exercise: $0.95Exp: 2017-04-25→ Common Stock (320,000 underlying)
    320,000

  • Stock Options

    Exercise: $0.17Exp: 2018-03-25→ Common Stock (1,100,000 underlying)
    1,100,000
Footnotes (7)
  • [F1]The option vested as to 73,334 shares on July 10, 2007, and as to 73,333 shares on each of July 10, 2008 and July 10, 2009.
  • [F2]The option vested as to 20,000 shares on each of July 10, 2007, July 10, 2008 and July 10, 2009.
  • [F3]The option vested as to 106,667 shares on each of April 25, 2008 and April 25, 2009. The remaining 106,666 shares are scheduled to vest on April 25, 2010.
  • [F4]The option vested as to 366,667 shares on each of March 25, 2008 and March 25, 2009. The remaining 366,666 shares are scheduled to vest on March 25, 2010.
  • [F5]The warrant is exercisable immediately.
  • [F6]On March 3, 2010, the reporting person was granted an option to purchase 2,000,000 shares of common stock of Manhattan Pharmaceuticals, Inc. under the 2003 Stock Option Plan.
  • [F7]The vesting schedule of the option is as follows: (i) 1,000,000 shares vested on the date of grant, (ii) 333,333 shares are scheduled to vest on each of March 3, 2011 and March 3, 2012, and (iii) 333,334 shares are scheduled to vest on March 3, 2013.

Documents

1 file

Issuer

MANHATTAN PHARMACEUTICALS INC

CIK 0001001316

→
Entity typeother

Related Parties

1
  • filerCIK 0001304506

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 6:15 PM ET
Size
13.6 KB
View on SEC.gov